P04-34. Identification of 4E10-like antibodies in plasma of an HIV-1 CRF02_AG infected patient with broad neutralizing activity using peptide phage libraries

by Heyndrickx L, Willems B, Dieltjens T, Vanham G
Published 2009-10-01

P04-14. Sequential HIV-1 isolates from infected individuals reveals emergence of neutralization sensitive HIV-1 strains in the course of infection

by Gorny MK, Vanham G, Heyndrickx L, Williams C, Burda S, Nyambi PN
Published 2009-10-01

P12-11. Resistance to the CD4 mimetic mini protein M48-U1 induces changes in a highly conserved region on the HIV-1 gp120 envelope protein

by Martin L, Martin G, Michiels J, Heyndrickx L, Grupping K, Vanham G
Published 2009-10-01

P04-52 LB. The importance of well-defined HIV-1 neutralization assays

by Lanzavecchia A, Corti D, Davis D, Heyndrickx L, Vereecken K, Willems B, Balla-Jhagjhoorsingh SS, Weiss R, Vanham G
Published 2009-10-01

Superimposing incident sexually transmitted infections on HIV phylogram to investigate possible misclassification of men who have sex with men as heterosexuals in a cohort in Antwe...

by Osbak, K.K., Meehan, Conor J., G. Ribas, S., Heyndrickx, L., Ariën, K.K., Tsoumanis, A., Florence, E., Esbroeck, M.V., Fransen, K., Kenyon, C.R.
Published 2019

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization

by Heyndrickx L, Stewart-Jones G, Schuitemaker H, Bowles E, Buonaguro L, Jansson M, Grevstad B, Vinner L, Ramaswamy M, Biswas P, Scarlatti G, Vanham G, Fomsgaard A
Published 2012-09-01

P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group

by Polonis V, Osmanov S, Morris L, Moog C, Montefiori D, Malnati M, Lopalco L, Jansson M, Holmes H, Heyndrickx L, Heath A, Fenyö E, Bongertz V, Alcami J, Scarlatti G, Ramaswamy M, Sattentau Q, Schuitemaker H, Wrin T
Published 2009-10-01